1. Main page
  2. Biotechnology
  3. Sinovac Biotech

Sinovac Biotech

2 Decision Makers · 2 Verified Contacts

sinovac.com
📍 Beijing, Beijing, ChinaBiotechnology🗓 Est. 2001👥 501–1000 employees

About Sinovac Biotech

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization

Leadership & Decision Makers

Contact details of 2 Sinovac Biotech decision makers

Weidong Yin

Founder & CEO

Nan Wang

Vice President, Business Development

General Emails

General company emails, e.g. customer support lines

    sinovac@sinovac.com

    Unclassified inbox

    gongxj@sinovac.com

    Unclassified inbox

    info@sinovac.com

    General Inquiries

    tangxy2403@sinovac.com

    Unclassified inbox

    cheyp@sinovac.com

    Unclassified inbox

    gongping@sinovac.com

    Unclassified inbox

Verify Sinovac Biotech Emails

Similar Companies like Sinovac Biotech

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Horizon Pharma

horizontherapeutics.com
Pharmaceuticals · Northbrook, Illinois, United States · Est. 2005 · 1001–5000 employees

HQ: Northbrook, Illinois, United States

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 30/07/2025

sinovac.com

+86 10 8289 0088

Beijing, Beijing, China

Specialization: Therapeutics,
Legal Name: Sinovac Biotech Co. Ltd.
Business Type: Delisted
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: 2001
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SVA
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +86 10 8289 0088
Last Investment Activity: Apr 26, 2024
Investments Activity: Apr 26, 2024 Jan 11, 2024 May 5, 2022

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.